Variation in plasminogen-activator-inhibitor-1 gene and risk of meningococcal septic shock

Lancet

Volumn 354, Issue 9178, 1999, Pages 561-563

  Westendorp, Rudi G J ^a   Hottenga, Jouke Jan ^b   Slagboom, P Eline ^b  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b TNO   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

PLASMINOGEN ACTIVATOR INHIBITOR 1;

ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; FIBRINOLYSIS; GENE FREQUENCY; GENOTYPE; HIGH RISK PATIENT; HUMAN; INFANT; MENINGOCOCCOSIS; NEISSERIA MENINGITIDIS; NORMAL HUMAN; PRIORITY JOURNAL; PROMOTER REGION; RELATIVE; SEPTIC SHOCK; SURVIVAL;

EID: 0033554267     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(98)09376-3     Document Type: Note

References (23)

1. Bohm N. Adrenal, cutaneous and myocardial lesions in fulminating endotoxemia. Pathol Res Pract. 174:1982;92-105.
2. Kilpi T., Anttila M., Kallio M.J.T., Peltola H. Severity of childhood bacterial meningitis and duration of illness before diagnosis. Lancet. 338:1991;406-409.
3. Moore K.L., Andreoli S.P., Esmon N.et al. Endotoxin enhances tissue factor and suppresses thrombomodulin expression of human vascular endothelium in vitro. J Clin Invest. 79:1987;124-130.
4. Andersen B.M., Solberg O., Bryn K.et al. Endotoxin liberation from Neisseria meningitidis isolated from carriers and clinical cases. Scand J Infect Dis. 19:1987;409-419.
5. Westendorp R.G.J., Reitsma P.H., Bertina R.M. Inherited prethrombotic disorders and infectious purpura. Thromb Haemost. 75:1996;899-901.
6. Levi M., ten Cate H., van der Poll T., van Deventer S.J.H. Pathogenesis of disseminated intravascular coagulation in sepsis. JAMA. 270:1993;975-979.
7. Paramo J.A., Perez J.L., Serrano M., Rocha E. Types 1 and 2 plasminogen activator inhibitor and tumour necrosis factor alpha in patient with sepsis. Thromb Haemost. 64:1990;3-6.
8. Mesters R.M., Florke N., Ostermann H., Kienast J. Increase of plasminogen activator inhibitor levels predicts outcome of leucocytopenic patients with sepsis. Thromb Haemost. 75:1996;902-907.
9. Brandtzaeg P., Joo G.B., Brusletto B., Kierulf P. Plasminogen activator inhibitor 1 and 2, alpha-2-antiplasmin, plasminogen, and endotoxin levels in systemic meningococcal disease. Thromb Res. 57:1990;271-278.
10. Westendorp R.G.J., Brand A., Haanen J.et al. Leukaplasmapheresis in meningococcal septic sock. Am J Med. 92:1992;577-578.
11. Kornelisse R.F., Hazelzet J.A., Savelkoul H.F.J.et al. The relationship between plasminogen activator inhibitor-1 and proinflammatory and counterinflammatory mediators in children with meningococcal septic shock. J Infect Dis. 173:1996;1148-1156.
12. Eriksson P., Kallin B., van't Hooft F.M.et al. Allele-specific increase in basal transcription of the plasminogen-activator inhibitor 1 gene is associated with myocardial infarction. Proc Natl Acad Sci USA. 92:1995;1851-1855.
13. Dawson S.J., Wiman B., Hamsten A.et al. The two allele sequences of a common polymorphism in the promoter of the plasminogen activator inhibitor 1 (PAI-1) gene respond differently to interleukin-1 in HepG2 cells. J Biol Chem. 268:1993;10739-10745.
14. Westendorp R.G.J., Langermans J.A.M., de Bel C.E.et al. Release of tumour necrosis factor: an innate host characteristic that contributes to the outcome of meningococcal disease. J Infect Dis. 71:1995;1057-1060.
15. Westendorp R.G.J., Langermans J.A.M., Huizinga T.W.J.et al. Genetic influence on cytokine production and fatal meningococcal disease. Lancet. 349:1994;170-173.
16. Mansfield M.W., Stickland M.H., Grant P.J. Plasminogen activator inhibitor-1 (PAI-1) polymorphism and coronary artery disease in non-insulin-dependent diabetes. Thromb Haemost. 74:1995;1032-1034.
17. Suffredeni A.F., Harpel P.C., Parillo J.E. Promotion and subsequent inhibition of plasminogen activation after administration of intravenous endotoxin to normal subjects. N Engl J Med. 320:1989;1165-1172.
18. Van Deventer S.J.H., Buller H.R., ten Cate H.et al. Experimental endotoxemia in humans: analysis of cytokine release and coagulation, fibrinolytic, and complement pathways. Blood. 76:1990;2520-2526.
19. Van Deuren M., van Dijke B.J., Koopman R.J.J.et al. Rapid diagnosis of acute meningococcal infections by needle aspiration or biopsy of skin lesions. BMJ. 306:1993;1229-1232.
20. Paloma M.J., Paramo J.A., Rocha E. Endotoxin-induced intravascular coagulation in rabbits: effect of tissue plasminogen activator vs urokinase on PAI generation, fibrin deposits and mortality. Thromb Haemost. 74:1995;1578-1582.
21. Van Dissel, van Langevelde P., Westendorp R.G.J.et al. Anti-inflammatory cytokine profile and mortality in febrile patients. Lancet. 351:1998;950-953.
22. Sorensen T.I.A., Nielsen G.G., Anderson P.K., Teasdale T.W. Genetic and environmental influences on premature death in adult adoptees. N Engl J Med. 318:1988;727-732.
23. Mohanty D., Gosh K., Nandwani S.K.et al. Fibrinolysis, inhibitors of blood coagulation, and monocyte derived coagulant activity in acute malaria. Am J Hematol. 54:1997;23-29.